Vortex Biotechnology Corporation is categorized under Research and Development Laboratories in Mount Pleasant, SC and active since 2008.
Vortex Biotechnology Corporation was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Charles D Smith at the company’s single location by writing to 26 Hopetown Road, Mount Pleasant, South Carolina SC 29464 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vortex Biotechnology Corporation |
| Contact Person: | Charles D Smith |
| Address: | 26 Hopetown Road, Mount Pleasant, South Carolina 29464 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Vortex Biotechnology Corporation was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles D Smith for inquiries that concern Vortex Biotechnology Corporation by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Vortex Biotechnology Corporation can be found at the coordinates 32.821794,-79.880799 as well as the street address 26 Hopetown Road in Mount Pleasant, South Carolina 29464.
For its online presence, you may visit Vortex Biotechnology Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.